Navigation Links
What controls stickiness of 'smart' chromosomal glue

Researchers have a new understanding of the process cells use to ensure that sperm and eggs begin life with exactly one copy of each chromosome ?a process that must be exquisitely regulated to prevent problems such as miscarriages and mental retardation. The new work reveals how gluelike protein complexes release pairs of chromosomes at precisely the moment of meiosis ?the specialized cell division process that produces sperm and eggs ?enabling them to separate properly.

The researchers, led by Howard Hughes Medical Institute investigator Angelika Amon, published their findings online May 3, 2006, in the journal Nature. Amon and her colleagues are at the Massachusetts Institute of Technology.

Most cells in the human body ?all those other than sperm and eggs ?contain 23 pairs of chromosomes. These cells divide through mitosis, a process that creates daughter cells with the same complement of chromosome pairs as the parent. Sperm and egg cells, on the other hand, must contain only half the chromosomes of their parent cells, so that the normal chromosome number will be restored when the sperm and egg unite during fertilization. To achieve this, they are produced through meiosis.

Gluelike protein complexes called cohesins, which hold the members of a chromosome pair together until just the right moment during cell division, are central to both processes. Bound together by cohesins, chromosome pairs must organize themselves in preparation for cell division before they can be released.

According to Amon, a deeper basic knowledge of the mechanism of cohesin loss during meiosis could ultimately improve understanding of the origins of miscarriages and mental retardation due to mis-segregation of chromosomes.

"We first need to understand the key regulatory players and the molecular mechanisms that cause chromosomes to segregate in this very unusual way during meiosis," she said. "Once we have a good enough understanding, then we c
'"/>

Source:Howard Hughes Medical Institute


Page: 1 2 3 4

Related biology news :

1. Cooperation is key—a new way of looking at MicroRNA and how it controls gene expression
2. Master gene controls healing of skin in fruit flies and mammals
3. Scientists find that protein controls aging by controlling insulin
4. MicroRNA tweaks protein that controls early heart development
5. Scientists discover gene that controls speed of tuberculosis development
6. Gene controls whether fear is a factor
7. Salk researchers make fast strides towards understanding how our body controls walking
8. Robotic joystick reveals how brain controls movement
9. Molecular on/off switch controls immune defenses against viruses
10. Pair of microRNA molecules controls major oncogene in most common leukemia
11. Fast and slow -- How the spinal cord controls the speed of movement

Post Your Comments:
(Date:11/24/2009)...ntists have crystallised a protein that may help g...e protein could be used by probiotic producers to ...efit to people. , "Probiotics need to interact wi...t, and if they attach to surfaces in the gut they ...rt their activity," says Dr Nathalie Juge from the...
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wi...a report revealing that the last remaining populat...cantly due to the rising tide of poaching and habi... help inform Russian officials of what needs to be...d,s biggest cat. , The report was r...
(Date:11/24/2009)...s release is available in Spanish . , The p...r levels of inflammatory substances in the blood, ...s shown by a research project of the University of...scientist at the School of Pharmacy. , The proje...y in relation to the control of body weight and in...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Report shows dramatic decline in Siberian tigers 2It can be predicted the reaction obese patients will have to a diet 2Nonprofit Goes RVing to Promote Pet and Human Health 48962 1Nonprofit Goes RVing to Promote Pet and Human Health 48962 2Nonprofit Goes RVing to Promote Pet and Human Health 48962 3HPV Vaccine Acceptability Study Announces Results 48959 1HPV Vaccine Acceptability Study Announces Results 48959 2HPV Vaccine Acceptability Study Announces Results 48959 3Heart Association Warns of Surgery Risks in Obese 48956 1Heart Association Warns of Surgery Risks in Obese 48956 2
...Walter J. Lukiw, PhD, Associate Professor of Neuro...Center New Orleans, is the lead author of a paper ...on of a fragment of ribonucleic acid (RNA), once t...ng inflammation and the development of Alzheimer,s...146a-mediated inflammatory circuit in Alzheimer,s ...
...SANTA CRUZ, CA--An unusual microorganism discovere...k their understanding of how carbon and nitrogen c... by Jonathan Zehr, professor of ocean sciences at ...rized the new microbe by analyzing its genetic mat...to grow it in the laboratory. , Zehr said the ne...
...CHAPEL HILL Researchers from the University of No...ve been awarded almost $10 million to study the ma...y affect interactions between mothers and their in...dings will aid the development of new intervention... and prove valuable to others working in fields su...
Other Biology News:LSUHSC research identifies key contributor to Alzheimer's disease process 2Mysterious microbe may play important role in ocean ecology 2Mysterious microbe may play important role in ocean ecology 3UNC, Yale partner to study effects of cocaine use on mother-infant relationships 2
(Date:11/24/2009)... The New York investment bank...ASX:NEU) has agreed an AU$6.7 mil convertible note...tor. The private placement was arranged by KTA Cap...isor. , New York (PRWEB) ...stment bank KTA Capital, LLC ("KTA Capital&qu...
(Date:11/24/2009)... , ST. LOUIS, Nov. 24 /PRNewswire-FirstCal...ill be presenting at the NASDAQ OMX conference on ...45 AM US/CST. Interested parties may listen via li... http://inve s tor.sig m a a ldrich.com/ ....s file. ,, About Sigma-Aldrich: Sigma-Ald...
(Date:11/24/2009)... , SAN MATEO, Calif., Nov. 24 /PRNewswire... biopharmaceutical company focused on developing a..., announced today that Anthony DiTonno, President ...nt at the 21st Annual Piper Jaffray Health Care Co... York Palace Hotel in New York, New York. ,, M...
(Date:11/24/2009)... , , Primary efficacy endpoint has been m...nt endometrial cancer, , QUEBEC CITY, Nov. 24...ASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global...erapy and oncology, today announced positive effic...totoxic peptide conjugate, AEZS-108 (formerly AN-1...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...ances Nfocus device development team. , , PALO AL... Nfocus Neuromedical Inc. announced today the ap...ert O,Holla to its leadership team in the role of ...,Holla brings an unmatched wealth of regulatory an... 18 of his last 30 years in the industry in the ro...
...idone role in treatment of patients with IPF - , ...t all-oral combination in HCV - , , - Strong data...in HCV - , , BRISBANE, Calif. , April 30 InterM...s from operations for the first quarter ended Marc...he first quarter of 2009 of $42.0 million, or $1.0...
...armaceuticals, Inc. (Nasdaq: IDIX ), a biopharma...lopment of drugs for the treatment of human viral ...ts for the first quarter ended March 31, 2009. At ...d marketable securities totaled $64.5 million. , ...st quarter of 2009, the company announced that it ...
Other Biology Technology:Nfocus Neuromedical Appoints Robert O'Holla to Head Regulatory 2InterMune Reports First Quarter 2009 Financial Results and Business Highlights 2InterMune Reports First Quarter 2009 Financial Results and Business Highlights 3InterMune Reports First Quarter 2009 Financial Results and Business Highlights 4InterMune Reports First Quarter 2009 Financial Results and Business Highlights 5InterMune Reports First Quarter 2009 Financial Results and Business Highlights 6InterMune Reports First Quarter 2009 Financial Results and Business Highlights 7InterMune Reports First Quarter 2009 Financial Results and Business Highlights 8InterMune Reports First Quarter 2009 Financial Results and Business Highlights 9InterMune Reports First Quarter 2009 Financial Results and Business Highlights 10InterMune Reports First Quarter 2009 Financial Results and Business Highlights 11InterMune Reports First Quarter 2009 Financial Results and Business Highlights 12InterMune Reports First Quarter 2009 Financial Results and Business Highlights 13Idenix Pharmaceuticals Reports First Quarter Financial Results 2Idenix Pharmaceuticals Reports First Quarter Financial Results 3Idenix Pharmaceuticals Reports First Quarter Financial Results 4Idenix Pharmaceuticals Reports First Quarter Financial Results 5Idenix Pharmaceuticals Reports First Quarter Financial Results 6
Goat Anti-KOR-1 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
T7Select1-1 OrientExpress cDNA Cloning System Random Primer from Novagen
Goat Anti-VAP-1 (S-13) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
... atoms at the 3, 3', 4, and 4' positions. It is in...ntification of Prostaglandin E2 (PGE2) by GC- or L...clooxygenase products of arachidonic acid and one ...s activity influences inflammation, fertility and ...
Biology Products: